People who have received the Pfizer vaccine have lower antibody levels that target the Delta variant, first discovered in India, than those that targeted previously circulating variants in the UK, new data suggests.
The study found that after just one dose of the Pfizer jab, people are less likely to develop antibody levels against the Delta variant, as high as those seen against the previously dominant Alpha variant, which was first discovered in Kent.
The study, from the Francis Crick Institute and the National Institute for Health Research, suggests the level of such antibodies are lower with older age and that the levels decline over time.
It is believed that this research provides additional evidence in support of a vaccination boost to vulnerable people in the autumn.
The new laboratory data also supports current plans to reduce the dose gap between vaccines.
Emma Wall, UCLH Infectious Diseases consultant and senior clinical research fellow for the Legacy study, said: “Our study is designed to be responsive to shifts in the pandemic so that we can quickly provide evidence on changing risk and protection.
“The most important thing is to ensure that vaccine protection remains high enough to keep as many people out of hospital as possible.
“And our results suggest that the best way to do this is to quickly deliver second doses and provide boosters to those whose immunity may not be high enough against these new variants.”
According to the research, in people who had received two doses of the Pfizer vaccine, levels of neutralising antibodies were more than five times lower against the Indian variant when compared to the original strain, upon which current vaccines are based.
This antibody response was even lower in people who had only received one dose.
The rare lung disease is so complicated that its acronym is difficult to pronounce. However, for infants who were unfortunate enough to be born with this disorder, the outcome is generally fatal. Left: normal [...]
Researchers analyzed data on three variants of concern and found that viral loads were higher and infection lasted longer for the B.1.1.7 variant. They all were more infectious than the original strain, and transmissibility [...]
A higher-than-expected number of young men have experienced heart inflammation after their second dose of the mRNA COVID-19 shots from Pfizer/BioNTech and Moderna, according to data from two vaccine safety monitoring systems, the U.S. [...]
Probably you’ve heard about hacking smartphones, emails, cards, computers. Even hacking elections. But what about hacking your body? What?! This concept is called biohacking and it’s really all about self-improvement. The possibilities are endless, all around [...]
Over the course of the coronavirus pandemic, various conspiracy theories surrounding the COVID-19 vaccine have arisen, with one of the most popular pieces of false information being that the shots contain microchips. Now, scientists [...]
COVID-19 continues to claim lives around the world and is infecting millions more. Although several vaccines have recently become available, making significant strides towards preventing COVID-19, what about the treatment of those who already [...]
People who have received the Pfizer vaccine have lower antibody levels that target the Delta variant, first discovered in India, than those that targeted previously circulating variants in the UK, new data suggests. The study found that [...]
Medical researchers with the Chinese army engineered mice with humanized lungs in 2019 to test viruses on them, it has been reported. The mice, developed using CRISPR gene-editing technology, were mentioned in an April 2020 study which researched [...]
Healthcare systems across Africa are “far from ready” to cope with a fresh surge of coronavirus infections, with vaccine deliveries at a near standstill and cases surging in many countries, the World Health Organization [...]
All viruses, including SARS-CoV-2, the virus that causes COVID-19, change over time. Most changes have little to no impact on the virus’ properties. However, some changes may affect the virus’s properties, such as how easily it spreads, the associated disease severity, or [...]
Vaccines can be great at preventing you from getting sick, while at the same time not necessarily stopping you from getting infected or spreading the germ. Preliminary evidence seems to suggest the COVID-19 vaccines [...]
People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer. Many people who have been infected with [...]
British spies believe that the thesis that COVID-19 leaked from a lab in China is plausible and are seeking to recruit sources on the darknet as they investigate the claim, reported The Sunday Times. Sources [...]
A team of German scientists believe that they have worked out why some people given the AstraZeneca and Johnson & Johnson vaccines against Covid-19 develop blood clots – and claim they can tell the manufacturers how to improve [...]
The United States is closer than ever to beating Covid-19, with half the country vaccinated and more restrictions lifting. But we're as far as ever from knowing how this virus, which shut down the world, [...]